CA9 and metastatic neoplasm: Here, we use a single RCC243 cell line harboring a VHL mutation that was established by selecting for a carbonic anhydrase IX (CA9) marker of ccRCC from the primary tumor of a ccRCC patient who was diagnosed with metastatic disease [10, 27].